|
|
| | 6-PIPERAZINONICOTINONITRILE Basic information |
| Product Name: | 6-PIPERAZINONICOTINONITRILE | | Synonyms: | 6-(Piperazin-1-yl);6-(Piperazin-1-yl)pyridine-3-carbonitrile, 1-(5-Cyanopyridin-2-yl)piperazine;6-Piperazinonicotinonitrile ,98%;6-(PIPERAZINO)PYRIDINE-3-CARBONITRILE;6-PIPERAZINONICOTINONITRILE;6-PIERAZINONICOTINONITRILE;2-(1-PIPERAZINO)PYRIDINE-5-CARBONITRILE;2-(PIPERAZIN-1-YL)-5-PYRIDINECARBONITRILE, 6-PIPERAZINONICOTINONITRILE | | CAS: | 149554-29-0 | | MF: | C10H12N4 | | MW: | 188.23 | | EINECS: | | | Product Categories: | PIPERIDINE;pharmacetical;Piperazines | | Mol File: | 149554-29-0.mol |  |
| | 6-PIPERAZINONICOTINONITRILE Chemical Properties |
| Melting point | 131 °C | | Boiling point | 403.2±40.0 °C(Predicted) | | density | 1.22±0.1 g/cm3(Predicted) | | storage temp. | Keep in dark place,Sealed in dry,Room Temperature | | form | Solid | | pka | 8.47±0.10(Predicted) | | CAS DataBase Reference | 149554-29-0(CAS DataBase Reference) |
| | 6-PIPERAZINONICOTINONITRILE Usage And Synthesis |
| Chemical Properties | Colorless to light yellow powder or chunks | | Uses | 6-Piperazinonicotinonitrile acts as a reagent in the synthesis and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for treatment of type 2 Diabetes. |
| | 6-PIPERAZINONICOTINONITRILE Preparation Products And Raw materials |
|